In this article, we discuss the 10 Best Stocks to Buy Right Now According to AI.
The US economy is navigating a complex and difficult environment defined by decelerating growth, persistent inflationary shocks, and a shifting consumer landscape. Fresh data released by the Bureau of Economic Analysis at the Commerce Department has fueled growing concerns over potential stagflation risks as the economy enters the second half of the year.The primary structural update comes from the revised gross domestic product (GDP) figures for the first quarter of 2026. Reuters reported that first-quarter GDP growth was downgraded to an annualized pace of 1.6%, a noticeable drop from the initial advance estimate of 2%. While this marks an improvement over the 0.5% growth rate recorded in the final quarter of 2025, the downward revision underscores a loss of domestic momentum. Economists polled by Reuters noted that this cooling was driven by a softer-than-expected print in consumer spending.
READ MORE: Michael Burry Stock Portfolio: Top 8 Stock Picks in 2026.
Simultaneously, the Federal Reserve’s preferred inflation gauge, the Personal Consumption Expenditures (PCE) price index, highlights stubborn upward price pressures. Driven heavily by surging energy and gasoline costs tied to the ongoing geopolitical conflict with Iran, the annual PCE price index jumped to 3.8% in April 2026. This represents the fastest annual increase in three years, matching consensus forecasts but complicating the central bank’s mandate. Core PCE, which excludes volatile food and energy costs, also crept upward to a 3.3% annual pace. With inflation outpacing wage gains and household disposable incomes falling for a third consecutive month, financial markets increasingly expect the Federal Reserve to maintain its benchmark overnight interest rate higher for longer, potentially extending current tight monetary policy well into 2027.
READ MORE: Graham Stephan Stock Portfolio: Top 11 Stocks.
Our Methodology
For this article, we selected stocks by asking AI engines to recommend investments. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q1 2026 database of 1041 elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Best Stocks to Buy Right Now According to AI
10. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company focused on developing therapies for patients suffering from rare neurological diseases. The flagship commercial product is WAKIX (pitolisant), a first-in-class medication approved by the FDA to treat excessive daytime sleepiness or cataplexy in adult patients with narcolepsy. Pitolisant functions through a novel mechanism of action that increases histamine release in the brain to promote wakefulness. Harmony is actively working to expand its market footprint by seeking regulatory approvals for pediatric narcolepsy and exploring treatments for idiopathic hypersomnia and Prader-Willi syndrome.
Harmony Biosciences Holdings, Inc. recently posted impressive Q1 2026 financial results, which featured total revenues of $215.4 million, representing a 17% year-over-year growth driven by the sustained adoption of WAKIX. Management reaffirmed its full-year 2026 net revenue guidance of over $1 billion, signaling durable commercial momentum and stable market demand. The business exhibits exceptional operating leverage, converting its top-line growth into strong cash generation that comfortably funds its late-stage clinical pipeline. Investors are particularly optimistic about Harmony’s lifecycle management strategies for pitolisant and its newer pipeline assets.
9. Align Technology, Inc. (NASDAQ:ALGN)
Align Technology, Inc. (NASDAQ:ALGN) is a leading global medical device company that pioneered the digital orthodontics market with its revolutionary Invisalign system. The company designs, manufactures, and markets clear aligners, intraoral scanners, and digital services tailored for dental professionals. Its core product portfolio features Invisalign clear aligners, which serve as an aesthetic alternative to traditional metal braces, alongside the iTero intraoral scanning systems that capture precise 3D dental impressions. By embedding proprietary data analytics and smart-track material technologies into its workflows, Align has treated millions of patients globally. The company operates a highly scalable digital platform connecting doctors and patients, which helps maximize practice efficiency.
Align Technology, Inc. had an exceptional Q1 2026 performance that comfortably beat market expectations across all core metrics. The company delivered total revenues of $1.04 billion, marking a 6.2% year-over-year increase, driven by record global shipments within its clear aligner segment. Non-GAAP earnings per share surged by 21% year-over-year to $2.58, outpacing analyst forecasts by more than 12% due to pricing power and manufacturing cost efficiencies. Profitability was outstanding, with GAAP gross margin expanding by 140 basis points to 70.8%, while non-GAAP operating margins climbed 250 basis points to 21.5%.
8. Centene Corporation (NYSE:CNC)
Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through Medicaid, Medicare, and the Health Insurance Marketplace via its Ambetter brand. Centene’s business model relies on securing large-scale state and federal contracts to manage healthcare delivery efficiently for complex populations. By utilizing localized care models and advanced data analytics, the company works to optimize patient health outcomes while systematically lowering overall medical care costs. Centene manages a vast member base spanning across all 50 states, making it an essential pillar of the domestic healthcare infrastructure.
READ ALSO: Mark Cuban Stock Portfolio: 8 Best Stocks to Buy.
Investor optimism around Centene Corporation is anchored by a stellar Q1 2026 earnings report where the company crushed consensus estimates on both the top and bottom lines. Total revenues reached $49.94 billion, up 7% year-over-year, driven by strong premium yields, state-directed payments, and growth in its prescription drug plan business. Centene reported a GAAP diluted EPS of $3.11 and an adjusted diluted EPS of $3.37, which beat Wall Street expectations by roughly $0.50 per share. Operationally, Centene demonstrated cost discipline, narrowing its health benefits ratio to 87.3% and tightening its SG&A ratio to 7.6%. The company secured critical multi-year state contract wins in Nevada, Iowa, and Mississippi.
7. Microsoft Corporation (NASDAQ:MSFT)
Microsoft Corporation (NASDAQ:MSFT) is a global technology powerhouse that dominates the enterprise software, cloud computing, and personal computing landscapes. The company’s growth engine is anchored by its Intelligent Cloud segment, featuring Azure, a comprehensive cloud platform providing infrastructure, platform, and software services. Microsoft has infused generative artificial intelligence across its entire product ecosystem through its Copilot suites, embedding advanced AI capabilities into Microsoft 365 productivity applications, Windows, and GitHub developer tools. The company’s diversified business model also spans enterprise LinkedIn services, Xbox gaming, and hardware lines.
Microsoft Corporation recently posted blockbuster Q1 2026 financial results, which demonstrated accelerating enterprise demand for its cloud and artificial intelligence infrastructure. Quarterly revenue surged 18% year-over-year to reach $77.7 billion, while GAAP diluted earnings per share jumped to $3.72, supported by a 24% increase in operating income. The crown jewel of the report was Azure, which posted a 40% revenue growth, proving that cloud spending continues to outpace available supply. Crucially, the company’s commercial remaining performance obligation, its contracted revenue backlog, skyrocketed by 51% to $392 billion, guaranteeing long-term revenue visibility.
6. Apple Inc. (NASDAQ:AAPL)
Apple Inc. (NASDAQ:AAPL) is a premier consumer technology company celebrated for its premium hardware, seamlessly integrated operating systems, and rapidly expanding services ecosystem. The company’s financial core revolves around the iconic iPhone, which commands exceptional brand loyalty and premium industry margins worldwide. Beyond hardware, Apple has cultivated an ecosystem of complementary devices, including the Apple Watch, iPad, Mac lineup, and AirPods. A central component of Apple’s long-term business strategy is its Services division, which monetizes an installed base of active devices through the App Store, Apple Music, iCloud, Apple Pay, and Apple TV+.
Apple Inc. had a record-shattering Q1 2026 financial performance that disproved macroeconomic headwinds and highlighted strong global demand. Apple posted an all-time quarterly revenue record of $143.8 billion, a 16% year-over-year increase, driven by an outstanding iPhone revenue print of $85.3 billion, which climbed 23% from the prior year. Diluted earnings per share rose 19% to $2.84, beating consensus estimates. The Services division achieved an all-time high of $30 billion in revenue, up 14% year-over-year, operating at an exceptional 76.5% gross margin. Apple’s global active installed base has officially surpassed 2.5 billion devices, providing an unmatched foundation for recurring digital revenue.
5. Palantir Technologies Inc. (NASDAQ:PLTR)
Palantir Technologies Inc. (NASDAQ:PLTR) is a specialized software company that builds and deploys advanced data analytics and artificial intelligence platforms for government agencies and commercial enterprises. The company’s core offerings include Palantir Gotham, designed for defense and intelligence sectors to identify patterns within disconnected datasets, and Palantir Foundry, which provides commercial corporations with a central operating system for institutional data. To capture the massive wave of enterprise AI demand, the company launched the Palantir Artificial Intelligence Platform (AIP), allowing organizations to bind large language models directly to their private networks and operational workflows safely.
Palantir Technologies Inc. business model centers on deep customer integration, using intensive bootcamps to demonstrate immediate operational value. The firm had an outstanding Q1 2026 earnings report. It delivered total quarterly revenue of $1.633 billion, surpassing Wall Street expectations of $1.54 billion and demonstrating strong growth at scale. Diluted earnings per share came in at $0.33, beating consensus estimates of $0.27 by over 22% and representing a massive increase from the $0.13 recorded in the prior-year period. This profitability expansion is driven by the rapid, widespread adoption of its AIP platform within the domestic commercial sector, where corporate customers are leveraging Palantir’s software to deploy operational AI agents.
4. Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) is a premier global pharmaceutical corporation dedicated to discovering, developing, and manufacturing innovative human medicines across multiple therapeutic areas. The company’s primary growth catalyst is its world-class cardiometabolic health portfolio, led by the highly successful tirzepatide molecule, marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Eli Lilly also maintains a prominent market presence in oncology with Jaypirca, immunology with Omvoh and Ebglyss, and neuroscience with Kisunla, an advanced treatment targeting Alzheimer’s disease.
Eli Lilly and Company relies on heavy reinvestment into clinical research and development, combined with expansion of global manufacturing capacity. The firm recently posted the Q1 2026 financial report that recorded total revenue of $19.8 billion, representing a 56% year-over-year increase, fueled almost entirely by the demand for Mounjaro and Zepbound, which collectively brought in $12.8 billion. Non-GAAP diluted earnings per share skyrocketed by 156% year-over-year to $8.55, vastly exceeding analyst forecasts of $6.97. Eli Lilly maintained a superb gross margin of 82.6%, while its non-GAAP performance margin expanded by 7 percentage points to 50%. Backed by this commercial momentum, management raised its full-year 2026 revenue guidance to $82 billion to $85 billion.
3. NVIDIA Corporation (NASDAQ:NVDA)
NVIDIA Corporation (NASDAQ:NVDA) is the pioneer of accelerated computing and the primary hardware architectural foundation for the global artificial intelligence revolution. Originally famous for inventing the Graphics Processing Unit (GPU) to revolutionize gaming graphics, the company has transformed into a full-stack accelerated computing enterprise. NVIDIA’s Data Center segment designs and deploys ultra-high-performance AI computing architectures, combining cutting-edge GPUs with proprietary NVLink interconnect networks and the specialized CUDA software ecosystem.
NVIDIA Corporation recently released Q1 2026 earnings which completely shattered all market expectations. It reported a record-breaking quarterly revenue of $81.62 billion, marking an 85% increase from the $44.01 billion recorded in the same period last year. Net income surged to $58.32 billion, yielding a diluted EPS of $2.39. This unprecedented surge was spearheaded by its Data Center division, which posted a record $75.2 billion in revenue, growing 92% year-over-year as global tech giants execute a collective $750 billion infrastructure buildout. NVIDIA’s gross margins and net profitability remain unmatched.
2. Broadcom Inc. (NASDAQ:AVGO)
Broadcom Inc. (NASDAQ:AVGO) is a diversified technology leader that designs, develops, and supplies a broad range of semiconductor and infrastructure software solutions. The company’s semiconductor division focuses on complex digital and mixed-signal complementary silicon devices, holding dominant market positions in wireless communications, data center networking, and custom application-specific integrated circuits (ASICs), which Broadcom categorizes as custom XPUs. Broadcom’s infrastructure software business, significantly strengthened by its acquisition of VMware, provides enterprise clients with critical virtualization, cybersecurity, and cloud management platforms.
Broadcom Inc. had a stellar fiscal Q1 2026 earnings report. Total revenue reached a record $19.3 billion, up 29% year-over-year, driven by a 106% explosion in AI semiconductor revenue to $8.4 billion. The firm posted an adjusted EBITDA of $13.1 billion, or 68% of revenue, alongside a consolidated operating margin of 66.4%. Investors are highly enthusiastic about Broadcom’s $73 billion AI backlog and its multi-year custom silicon partnerships with hyperscalers like Google and Meta. Management provided guidance for Q2 2026, forecasting revenue to climb to $22 billion, representing 47% year-over-year growth, with AI semiconductor sales accelerating to $10.7 billion.
1. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is the world’s largest dedicated pure-play semiconductor foundry, serving as the essential manufacturing backbone for the global technology industry. Operating an advanced manufacturing model, TSMC does not design or market its own branded chips; instead, it manufactures semiconductors for the world’s leading technology and chip design firms, including Apple, NVIDIA, AMD, and Broadcom. The company commands an absolute monopoly in leading-edge process nodes, specifically its 3-nanometer and 5-nanometer technologies, which are required to build advanced AI accelerators, high-performance computing systems, and smartphone processors.
Financially, Taiwan Semiconductor Manufacturing Company Limited is undeniably strong, especially based on its record-breaking Q1 2026 earnings presentation. In the first three months of the year, the chip giant reported consolidated quarterly revenue of $35.9 billion, representing a 40.6% year-over-year increase, with 3nm and 5nm technologies accounting for 61% of total wafer revenues. TSMC’s elite pricing power was evident as gross margins reached 66.2%, prompting management to revise its long-term gross margin target upward to 56% and above through the market cycle. Driven by booming demand for AI accelerators, Taiwan Semiconductor Manufacturing raised its full-year 2026 revenue growth guidance to above 30% in US dollar terms.
READ NEXT: Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn and Chris Rokos Stock Portfolio: Top 10 Stock Picks.
READ NEXT: Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn and Chris Rokos Stock Portfolio: Top 10 Stock Picks.
Hedge Fund Resource Center